ORFADIN
Google image searchProduct monograph
Active ingredient
nitisinone, 4 MG/ML
DIN: 02469693
Dosage form(s): SUSPENSION
Route(s) of administration: ORAL
Schedule: Prescription
Company: SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Date: 10-JUL-2018
ATC:
- A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
- A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
- A16AX — Various alimentary tract and metabolism products (ATC, ATC/DDD)
- A16AX04 — NITISINONE (ATC/DDD)
Reference brand drug: Orfadin
